Asai, Shuji http://orcid.org/0000-0002-4030-8793
Takahashi, Nobunori
Terabe, Kenya
Sobue, Yasumori
Nishiume, Tsuyoshi
Suzuki, Mochihito
Yokota, Yutaka
Ishiguro, Naoki
Kojima, Toshihisa
Article History
Received: 14 February 2020
Revised: 10 April 2020
Accepted: 1 May 2020
First Online: 16 May 2020
Compliance with ethical standards
:
: SA has received speakers’ fees from AbbVie, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Janssen, Takeda, and UCB Japan. NT has received speakers’ fees from AbbVie, Asahi Kasei, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Janssen, Mitsubishi Tanabe, Ono, Pfizer, Takeda, and UCB Japan. YS has received speakers’ fees from Astellas, Bristol-Myers Squibb, and Ono. MS has received speakers’ fees from Bristol-Myers Squibb. NI has received grant/research support, consulting fees, and/or speakers’ fees from AbbVie, Asahi Kasei, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Kaken, Mitsubishi Tanabe, Ono, Otsuka, Pfizer, Taisho Toyama, Takeda, and Zimmer Biomet. TK has received grant/research support and/or speakers’ fees from AbbVie, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eli Lilly, Janssen, Mitsubishi Tanabe, Novartis, Pfizer, and Takeda. The other authors declare no conflicts of interest.
: This study was approved by the Ethics Committee of Nagoya University Graduate School of Medicine (2019-0230) and complied with the principles set forth in the Declaration of Helsinki.
: Informed consent was obtained by an opt-out procedure.